UniProt ID | HPT_HUMAN | |
---|---|---|
UniProt AC | P00738 | |
Protein Name | Haptoglobin | |
Gene Name | HP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 406 | |
Subcellular Localization | Secreted. | |
Protein Description | As a result of hemolysis, hemoglobin is found to accumulate in the kidney and is secreted in the urine. Haptoglobin captures, and combines with free plasma hemoglobin to allow hepatic recycling of heme iron and to prevent kidney damage. Haptoglobin also acts as an Antimicrobial; Antioxidant, has antibacterial activity and plays a role in modulating many aspects of the acute phase response. Hemoglobin/haptoglobin complexes are rapidely cleared by the macrophage CD163 scavenger receptor expressed on the surface of liver Kupfer cells through an endocytic lysosomal degradation pathway.; Uncleaved haptoglogin, also known as zonulin, plays a role in intestinal permeability, allowing intercellular tight junction disassembly, and controlling the equilibrium between tolerance and immunity to non-self antigens.. | |
Protein Sequence | MSALGAVIALLLWGQLFAVDSGNDVTDIADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTEGDGVYTLNDKKQWINKAVGDKLPECEADDGCPKPPEIAHGYVEHSVRYQCKNYYKLRTEGDGVYTLNNEKQWINKAVGDKLPECEAVCGKPKNPANPVQRILGGHLDAKGSFPWQAKMVSHHNLTTGATLINEQWLLTTAKNLFLNHSENATAKDIAPTLTLYVGKKQLVEIEKVVLHPNYSQVDIGLIKLKQKVSVNERVMPICLPSKDYAEVGRVGYVSGWGRNANFKFTDHLKYVMLPVADQDQCIRHYEGSTVPEKKTPKSPVGVQPILNEHTFCAGMSKYQEDTCYGDAGSAFAVHDLEEDTWYATGILSFDKSCAVAEYGVYVKVTSIQDWVQKTIAEN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 | Phosphorylation | GQLFAVDSGNDVTDI HHHHCCCCCCCCHHC | 32.66 | 26657352 | |
53 | Glycation | HSVRYQCKNYYKLRT EEHHHEECCEEEEEE | 32.24 | - | |
53 | Acetylation | HSVRYQCKNYYKLRT EEHHHEECCEEEEEE | 32.24 | 27178108 | |
55 | Phosphorylation | VRYQCKNYYKLRTEG HHHEECCEEEEEECC | 6.35 | - | |
56 | Phosphorylation | RYQCKNYYKLRTEGD HHEECCEEEEEECCC | 16.97 | - | |
57 | Acetylation | YQCKNYYKLRTEGDG HEECCEEEEEECCCC | 22.57 | 27178108 | |
66 | Phosphorylation | RTEGDGVYTLNDKKQ EECCCCEEECCCHHH | 15.84 | - | |
71 | Acetylation | GVYTLNDKKQWINKA CEEECCCHHHHHHHH | 45.87 | 27178108 | |
72 | Acetylation | VYTLNDKKQWINKAV EEECCCHHHHHHHHH | 54.45 | 27178108 | |
77 | Acetylation | DKKQWINKAVGDKLP CHHHHHHHHHHCCCC | 35.00 | 27178108 | |
112 | Acetylation | HSVRYQCKNYYKLRT EEHHHEECCEEEEEE | 32.24 | 27178108 | |
114 | Phosphorylation | VRYQCKNYYKLRTEG HHHEECCEEEEEECC | 6.35 | - | |
115 | Phosphorylation | RYQCKNYYKLRTEGD HHEECCEEEEEECCC | 16.97 | - | |
116 | Acetylation | YQCKNYYKLRTEGDG HEECCEEEEEECCCC | 22.57 | 27178108 | |
125 | Phosphorylation | RTEGDGVYTLNNEKQ EECCCCEEECCCCCH | 15.84 | - | |
131 | Acetylation | VYTLNNEKQWINKAV EEECCCCCHHHHHHH | 53.72 | 27178108 | |
136 | Acetylation | NEKQWINKAVGDKLP CCCHHHHHHHHCCCC | 35.00 | 27178108 | |
170 | Acetylation | LGGHLDAKGSFPWQA HCCCCCCCCCCCCCE | 55.54 | 7666885 | |
184 | N-linked_Glycosylation | AKMVSHHNLTTGATL EEECEECCCCCCCEE | 33.39 | 17623646 | |
184 | N-linked_Glycosylation | AKMVSHHNLTTGATL EEECEECCCCCCCEE | 33.39 | 18514042 | |
187 | O-linked_Glycosylation | VSHHNLTTGATLINE CEECCCCCCCEEECH | 28.16 | OGP | |
207 | N-linked_Glycosylation | TAKNLFLNHSENATA HHHHHHHCCCCCCCH | 29.33 | 17623646 | |
207 | N-linked_Glycosylation | TAKNLFLNHSENATA HHHHHHHCCCCCCCH | 29.33 | 18638581 | |
211 | N-linked_Glycosylation | LFLNHSENATAKDIA HHHCCCCCCCHHHHH | 45.68 | 16740002 | |
211 | N-linked_Glycosylation | LFLNHSENATAKDIA HHHCCCCCCCHHHHH | 45.68 | 18638581 | |
241 | N-linked_Glycosylation | EKVVLHPNYSQVDIG EEEEECCCCCCCCEE | 38.04 | 19838169 | |
241 | N-linked_Glycosylation | EKVVLHPNYSQVDIG EEEEECCCCCCCCEE | 38.04 | 18514042 | |
242 | Phosphorylation | KVVLHPNYSQVDIGL EEEECCCCCCCCEEE | 12.63 | 26270265 | |
243 | Phosphorylation | VVLHPNYSQVDIGLI EEECCCCCCCCEEEE | 30.30 | 26270265 | |
251 | Ubiquitination | QVDIGLIKLKQKVSV CCCEEEEEEECCCCC | 55.46 | - | |
266 | S-nitrosylation | NERVMPICLPSKDYA CCCEECEECCCCCCE | 3.64 | 25040305 | |
269 | Phosphorylation | VMPICLPSKDYAEVG EECEECCCCCCEEEC | 25.80 | 24719451 | |
272 | Phosphorylation | ICLPSKDYAEVGRVG EECCCCCCEEECCEE | 14.38 | - | |
280 | Phosphorylation | AEVGRVGYVSGWGRN EEECCEEEECCCCCC | 6.65 | 21253578 | |
298 | Phosphorylation | KFTDHLKYVMLPVAD CCCCCCEEEEEEECC | 9.46 | 24114839 | |
309 | S-nitrosylation | PVADQDQCIRHYEGS EECCHHHHHHHCCCC | 3.87 | 25040305 | |
316 | Phosphorylation | CIRHYEGSTVPEKKT HHHHCCCCCCCCCCC | 17.81 | 28270605 | |
317 | O-linked_Glycosylation | IRHYEGSTVPEKKTP HHHCCCCCCCCCCCC | 51.44 | OGP | |
317 | Phosphorylation | IRHYEGSTVPEKKTP HHHCCCCCCCCCCCC | 51.44 | 28270605 | |
321 | Glycation | EGSTVPEKKTPKSPV CCCCCCCCCCCCCCC | 56.74 | - | |
321 | Acetylation | EGSTVPEKKTPKSPV CCCCCCCCCCCCCCC | 56.74 | 7683315 | |
323 | Phosphorylation | STVPEKKTPKSPVGV CCCCCCCCCCCCCCC | 47.20 | 23312004 | |
326 | Phosphorylation | PEKKTPKSPVGVQPI CCCCCCCCCCCCHHC | 26.48 | 24719451 | |
340 | S-nitrosylation | ILNEHTFCAGMSKYQ CCCCCEEEECCCCCC | 3.17 | 25040305 | |
381 | S-nitrosylation | ILSFDKSCAVAEYGV EEEECCCCEEEECEE | 4.32 | 25040305 | |
386 | Phosphorylation | KSCAVAEYGVYVKVT CCCEEEECEEEEEEE | 11.36 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of HPT_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HPT_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HPT_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HBB_HUMAN | HBB | physical | 7378053 | |
TGM2_HUMAN | TGM2 | physical | 21988832 | |
RL11_HUMAN | RPL11 | physical | 21988832 | |
LAMC3_HUMAN | LAMC3 | physical | 21988832 | |
SMAD3_HUMAN | SMAD3 | physical | 21988832 | |
TBL1X_HUMAN | TBL1X | physical | 21988832 | |
P63_HUMAN | TP63 | physical | 21988832 | |
WASL_HUMAN | WASL | physical | 21988832 | |
MVP_HUMAN | MVP | physical | 21988832 | |
APOA1_HUMAN | APOA1 | physical | 15533931 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614081 | Anhaptoglobinemia (AHP) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Enrichment of glycopeptides for glycan structure and attachment siteidentification."; Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,Brinkmalm G., Larson G.; Nat. Methods 6:809-811(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-241, CARBOHYDRATESTRUCTURE, AND MASS SPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-207; ASN-211 ANDASN-241, AND MASS SPECTROMETRY. | |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-207 AND ASN-211, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-207; ASN-211 ANDASN-241, AND MASS SPECTROMETRY. | |
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry."; Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; Proteomics 4:454-465(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-207; ASN-211 ANDASN-241, AND MASS SPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-207 AND ASN-241. |